Company profile
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
- Industry
- Biotechnology Research
- Employees
- 389
- Headquarters
- Rockville, Maryland
- Founded
- 2008
- LinkedIn followers
- 50,616
- Office locations
- 1
REGENXBIO company summary
REGENXBIO is a company in the Biotechnology Research industry, headquartered in Rockville, Maryland, founded in 2008. On LinkedIn the company has around 389 employees and 50,616 followers. Its listed specialties include Biotechnology, Biopharmaceuticals, Gene Therapy.
What technology does REGENXBIO use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About REGENXBIO
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Specialties
Where is REGENXBIO located?
REGENXBIO lists 1 location.
Compare companies similar to REGENXBIO
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
REGENXBIO regenxbio.com | Biotechnology Research | 389 | 2008 | Rockville, Maryland |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about REGENXBIO
What does REGENXBIO do?
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
How many employees does REGENXBIO have?
REGENXBIO has around 389 employees on LinkedIn.
Where is REGENXBIO headquartered?
REGENXBIO is headquartered in Rockville, Maryland.
When was REGENXBIO founded?
REGENXBIO was founded in 2008.
Build a lead list from companies like REGENXBIO
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.